Medical Technology Association of Canada (Medtech Canada)

Meetings over time

• Jun 20252 meetingsJade Mallette, Sandenga Yeba
  Jun 2025: 2 meetings, with Jade Mallette, Sandenga Yeba
• Jul 20251 meetingGalen Richardson
  Jul 2025: 1 meeting, with Galen Richardson
• Aug 20252 meetingsRodrigo Arancibia, Niloo Boroun
  Aug 2025: 2 meetings, with Rodrigo Arancibia, Niloo Boroun
• Sep 20252 meetingsRitu Banerjee, Rodrigo Arancibia
  Sep 2025: 2 meetings, with Ritu Banerjee, Rodrigo Arancibia
• Oct 20250 meetings
  Oct 2025: 0 meetings
• Nov 20252 meetingsRodrigo Arancibia, David McFarlane, Manuela Tomic
  Nov 2025: 2 meetings, with Rodrigo Arancibia, David McFarlane, Manuela Tomic
• Dec 20250 meetings
  Dec 2025: 0 meetings
• Jan 20260 meetings
  Jan 2026: 0 meetings
• Feb 20260 meetings
  Feb 2026: 0 meetings
• Mar 20260 meetings
  Mar 2026: 0 meetings
• Apr 20262 meetingsShalene Curtis-Micallef, Rodrigo Arancibia
  Apr 2026: 2 meetings, with Shalene Curtis-Micallef, Rodrigo Arancibia
• May 20261 meetingkaitlyn Pritchard
  May 2026: 1 meeting, with kaitlyn Pritchard
• Jun 20260 meetings
  Jun 2026: 0 meetings
• Jul 20261 meetingHelena Jaczek
  Jul 2026: 1 meeting, with Helena Jaczek

Hover or focus a month to see who was met.

What they lobby about

• Health13
• Science and Technology13
• Economic Development12
• Government Procurement10
• International Trade9
• International Relations8
• Taxation and Finance6
• Industry4
• Research and Development4
• Federal-Provincial Relations1
• Foreign Affairs1

The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.

Who they met

Innovation, Science and Economic Development Canada (ISED) (8) · Health Canada (HC) (5) · Intergovernmental Affairs Secretariat (IGA) (1) · House of Commons (1) · Finance Canada (FIN) (1) · Global Affairs Canada (GAC) (1)

In their own words

• Innovation, Science and Economic Development Canada - advocating that the federal government work across all government relevant Ministries and with key stakeholders to advance the adoption of novel and innovative health innovations and grow the medical technology industry in Canada including forming a permanent cross ministerial and stakeholder collaborative roundtable/advisory group. Advocating for the development of a commercialization framework and adoption of medical technologies & health innovations strategy in Canada.
• Discussions re. Policies to incent global medical technology companies to invest their R&D dollars in Canada, changes to the Scientific Research and Experimental Development tax credit and the impact on medical technology companies in Canada, the adoption of a common national framework to measuring health outcomes resulting in greater efficiencies and lower costs.
• Communicate with government on behalf of members, regarding the impact of changes to Canada-US Trade agreements, as they apply to medical technologies.